Pharmac funding u-turn for patients

Associate Health Minister David Seymour says the oestradiol patch funding decision is an example of Pharmac’s new patient-centric approach. From December 2025 Pharmac will fund two brands of oestradiol patches, Estradot and Estradiol TDP Mylan. “Pharmac received significant feedback at the end of last year about a decision to move to Estradiol TDP Mylan as the only funded brand of oestradiol patch.